Piper Sandler Reiterates Overweight on Braze, Maintains $27 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.7%

Neg 0% Neu 85.7% Pos 0%

Piper Sandler analyst Billy Fitzsimmons reiterates Braze (NASDAQ:BRZE) with a Overweight and maintains $27 price target.